Acute myocardial infarction in a young man: A consequence of inherited thrombophilia and marijuana smoking [3]

Thrombosis and Haemostasis

Volumn 95, Issue 6, 2006, Pages 1044-

  Taher, Ali T ^a   Mahfouz, Rami A R ^a   Otrock, Zaher K ^a   Rebeiz, Abdallah G ^a   Sawaya, Jaber I ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; CANNABIS; CLOPIDOGREL; DRONABINOL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STREPTOKINASE;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; BLOOD CLOT LYSIS; CASE REPORT; CORONARY ARTERY DISEASE; DISEASE SEVERITY; DRUG SCREENING; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FAMILY HISTORY; FOLLOW UP; GENE MUTATION; HEART CATHETERIZATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART PALPITATION; HUMAN; LABORATORY TEST; LETTER; MALE; PATIENT EDUCATION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RARE DISEASE; RISK ASSESSMENT; SMOKING; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; SWEATING; THORAX PAIN; THROMBOPHILIA;

ADULT; FACTOR V; HUMANS; MALE; MARIJUANA SMOKING; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS; THROMBOPHILIA;

EID: 33745297997     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH06-03-0169     Document Type: Letter

References (6)

1. Sidney S. Cardiovascular consequences of marijuana use. J Clin Pharmacol 2002; 42: 64S-70S.
2. Nassar NT, Melikian LH, Der-Karabetian A. Studies in the non medical use of drugs in Lebanon. I. The non medical use of marijuana, LSD, and amphetamine by students at the American University of Beirut. J Med Liban 1973; 26: 215-32.
3. Lindsay AC, Foale RA, Warren O, et al. Cannabis as a precipitant of cardiovascular emergencies. Int J Cardiol 2005; 104: 230-2.
4. Rosendaal FR, Koster T, Vandenbroucke JP, et al. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504-8.
5. Doggen CJ, Cats VM, Bertina RM, et al. Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A. Circulation 1998; 97: 1037-41.
6. Irani-Hakime N, Tamim H, Kreidy R, et al. The prevalence of factor V R506Q mutation-Leiden among apparently healthy Lebanese. Am J Hematol 2000; 65: 45-9.